A citation-based method for searching scientific literature

Julie Lotharius, Patrik Brundin. Nat Rev Neurosci 2002
Times Cited: 745







List of co-cited articles
728 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Alpha-synuclein in Lewy bodies.
M G Spillantini, M L Schmidt, V M Lee, J Q Trojanowski, R Jakes, M Goedert. Nature 1997
12

Epidemiology of Parkinson's disease.
Lonneke M L de Lau, Monique M B Breteler. Lancet Neurol 2006
11

Parkinson disease.
Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
9

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
9

The role of oxidative stress in Parkinson's disease.
Vera Dias, Eunsung Junn, M Maral Mouradian. J Parkinsons Dis 2013
739
9

Parkinson's disease: mechanisms and models.
William Dauer, Serge Przedborski. Neuron 2003
8

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
8

Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.
Isabel Ortuño-Lizarán, Thomas G Beach, Geidy E Serrano, Douglas G Walker, Charles H Adler, Nicolás Cuenca. Mov Disord 2018
59
11


Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
M H Polymeropoulos, C Lavedan, E Leroy, S E Ide, A Dehejia, A Dutra, B Pike, H Root, J Rubenstein, R Boyer,[...]. Science 1997
7

Non-motor symptoms of Parkinson's disease: diagnosis and management.
K Ray Chaudhuri, Daniel G Healy, Anthony H V Schapira. Lancet Neurol 2006
6

Epidemiology of Parkinson's disease.
Ole-Bjørn Tysnes, Anette Storstein. J Neural Transm (Vienna) 2017
619
6

Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.
Lena F Burbulla, Pingping Song, Joseph R Mazzulli, Enrico Zampese, Yvette C Wong, Sohee Jeon, David P Santos, Judith Blanz, Carolin D Obermaier, Chelsee Strojny,[...]. Science 2017
311
6

Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.
Jacqueline Burré, Manu Sharma, Theodoros Tsetsenis, Vladimir Buchman, Mark R Etherton, Thomas C Südhof. Science 2010
996
6

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
A J Hughes, S E Daniel, L Kilford, A J Lees. J Neurol Neurosurg Psychiatry 1992
6

MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
6

The function of α-synuclein.
Jacob T Bendor, Todd P Logan, Robert H Edwards. Neuron 2013
391
6

Hereditary early-onset Parkinson's disease caused by mutations in PINK1.
Enza Maria Valente, Patrick M Abou-Sleiman, Viviana Caputo, Miratul M K Muqit, Kirsten Harvey, Suzana Gispert, Zeeshan Ali, Domenico Del Turco, Anna Rita Bentivoglio, Daniel G Healy,[...]. Science 2004
6

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
R Krüger, W Kuhn, T Müller, D Woitalla, M Graeber, S Kösel, H Przuntek, J T Epplen, L Schöls, O Riess. Nat Genet 1998
6

Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C Hirsch, Stéphane Hunot. Lancet Neurol 2009
5


Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.
T Kitada, S Asakawa, N Hattori, H Matsumine, Y Yamamura, S Minoshima, M Yokochi, Y Mizuno, N Shimizu. Nature 1998
5

Neurodegenerative diseases and oxidative stress.
Kevin J Barnham, Colin L Masters, Ashley I Bush. Nat Rev Drug Discov 2004
5

Stages in the development of Parkinson's disease-related pathology.
Heiko Braak, Estifanos Ghebremedhin, Udo Rüb, Hansjürgen Bratzke, Kelly Del Tredici. Cell Tissue Res 2004
5

Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.
Ana Maria Cuervo, Leonidas Stefanis, Ross Fredenburg, Peter T Lansbury, David Sulzer. Science 2004
5

Parkinson's disease: clinical features and diagnosis.
J Jankovic. J Neurol Neurosurg Psychiatry 2008
5

The many faces of α-synuclein: from structure and toxicity to therapeutic target.
Hilal A Lashuel, Cassia R Overk, Abid Oueslati, Eliezer Masliah. Nat Rev Neurosci 2013
830
5

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.
K A Conway, J C Rochet, R M Bieganski, P T Lansbury. Science 2001
836
5

The epidemiology of Parkinson's disease: risk factors and prevention.
Alberto Ascherio, Michael A Schwarzschild. Lancet Neurol 2016
587
5

Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
R Betarbet, T B Sherer, G MacKenzie, M Garcia-Osuna, A V Panov, J T Greenamyre. Nat Neurosci 2000
5

Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.
Jin-Sung Park, Ryan L Davis, Carolyn M Sue. Curr Neurol Neurosci Rep 2018
174
5

Parkin is recruited selectively to impaired mitochondria and promotes their autophagy.
Derek Narendra, Atsushi Tanaka, Der-Fen Suen, Richard J Youle. J Cell Biol 2008
5

In vivo demonstration that alpha-synuclein oligomers are toxic.
Beate Winner, Roberto Jappelli, Samir K Maji, Paula A Desplats, Leah Boyer, Stefan Aigner, Claudia Hetzer, Thomas Loher, Marçal Vilar, Silvia Campioni,[...]. Proc Natl Acad Sci U S A 2011
881
5

alpha-Synuclein locus triplication causes Parkinson's disease.
A B Singleton, M Farrer, J Johnson, A Singleton, S Hague, J Kachergus, M Hulihan, T Peuralinna, A Dutra, R Nussbaum,[...]. Science 2003
5


Decreased dopamine in the retinas of patients with Parkinson's disease.
C Harnois, T Di Paolo. Invest Ophthalmol Vis Sci 1990
241
4

Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.
Laura A Volpicelli-Daley, Kelvin C Luk, Tapan P Patel, Selcuk A Tanik, Dawn M Riddle, Anna Stieber, David F Meaney, John Q Trojanowski, Virginia M-Y Lee. Neuron 2011
828
4

PINK1 is selectively stabilized on impaired mitochondria to activate Parkin.
Derek P Narendra, Seok Min Jin, Atsushi Tanaka, Der-Fen Suen, Clement A Gautier, Jie Shen, Mark R Cookson, Richard J Youle. PLoS Biol 2010
4

Structure of the toxic core of α-synuclein from invisible crystals.
Jose A Rodriguez, Magdalena I Ivanova, Michael R Sawaya, Duilio Cascio, Francis E Reyes, Dan Shi, Smriti Sangwan, Elizabeth L Guenther, Lisa M Johnson, Meng Zhang,[...]. Nature 2015
325
4

Neuroinflammation in Parkinson's disease and its potential as therapeutic target.
Qinqin Wang, Yingjun Liu, Jiawei Zhou. Transl Neurodegener 2015
349
4

A role for alpha-synuclein in the regulation of dopamine biosynthesis.
Ruth G Perez, Jack C Waymire, Eva Lin, Jen J Liu, Fengli Guo, Michael J Zigmond. J Neurosci 2002
448
4

Parkinson disease.
R Balestrino, A H V Schapira. Eur J Neurol 2020
136
4

Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2.
Jiajie Diao, Jacqueline Burré, Sandro Vivona, Daniel J Cipriano, Manu Sharma, Minjoung Kyoung, Thomas C Südhof, Axel T Brunger. Elife 2013
186
4

Alpha-Synuclein is degraded by both autophagy and the proteasome.
Julie L Webb, Brinda Ravikumar, Jane Atkins, Jeremy N Skepper, David C Rubinsztein. J Biol Chem 2003
4

Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies.
Asterios Chrysou, Nomdo M Jansonius, Teus van Laar. Parkinsonism Relat Disord 2019
30
13

α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease.
Paul M Levine, Ana Galesic, Aaron T Balana, Anne-Laure Mahul-Mellier, Mariana X Navarro, Cesar A De Leon, Hilal A Lashuel, Matthew R Pratt. Proc Natl Acad Sci U S A 2019
76
5

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
Mike A Nalls, Nathan Pankratz, Christina M Lill, Chuong B Do, Dena G Hernandez, Mohamad Saad, Anita L DeStefano, Eleanna Kara, Jose Bras, Manu Sharma,[...]. Nat Genet 2014
4

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.
Bin Zheng, Zhixiang Liao, Joseph J Locascio, Kristen A Lesniak, Sarah S Roderick, Marla L Watt, Aron C Eklund, Yanli Zhang-James, Peter D Kim, Michael A Hauser,[...]. Sci Transl Med 2010
509
4

A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci.
Diana Chang, Mike A Nalls, Ingileif B Hallgrímsdóttir, Julie Hunkapiller, Marcel van der Brug, Fang Cai, Geoffrey A Kerchner, Gai Ayalon, Baris Bingol, Morgan Sheng,[...]. Nat Genet 2017
510
4

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.
M G Spillantini, R A Crowther, R Jakes, M Hasegawa, M Goedert. Proc Natl Acad Sci U S A 1998
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.